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ABSTRACT 
In this paper we discuss the demand triggers and the components of consumer decision making 
to undertake medical tourism i.e. travel to a foreign destination for the purpose of availing 
medical treatment and also engaging in a vacation experience. We develop a model that 
describes the macro facilitating factors, the pre-decision propensities, and the role of the different 
entities involved in the tourism experience that impact the travel decision from a stakeholder 
perspective. Our conceptual model provides several propositions for empirical testing as well as 
directions for future research on medical tourism, a rich context for tourism scholars. 
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INTRODUCTION 
 
 
Travel for health, medical and medicinal purposes can be traced back to the Sumerian, 
Greek and earlier civilizations, whose elite members traveled to experience hot springs, bathe in 
mineral waters and for general rest and relaxation.  While modern civilizations still travel to hot 
springs and spas, the concept of medical tourism has evolved considerably from those early 
times.  As a niche industry within the tourism domain, medical tourism is generally understood 
to occur when “people travel often long distances to overseas countries to obtain medical, dental 
and surgical care while simultaneously being holidaymakers, in a more conventional sense” 
(Connell, 2006). 
 
 While people from less developed countries have often visited, and continue to visit,   
developed countries such as US and UK to avail of cutting –edge medical facilities and highly 
skilled physicians, this trend began to reverse in the 1990s and the term medical tourism came to 
refer to people from developed countries travelling to emerging economies with the intention of 
combining health care with holidaying.  With the aging population demographic in developed 
countries that increases demand, and the shortage of trained doctors (Suzanne Satalien, April 12, 
2010), leading to increasing health care costs results in an unfulfilled demand for medical 
services, a gap occurs, one that several countries seek to fill.  According to World Health 
Organization (WHO), in 2000, U.S. spent 13.2 percent of the GDP on its health care, by the 2007 
this went up to 15.7 percent (WHO, 2010), and is estimated to be 19.3% by 2019 (Truffer et al., 
2010).  Not only are the expenditures and the costs of health care rising but there are growing 
numbers of people without health insurance coverage; the US Census Bureau shows that the 
number of such persons rose from 45.7 million in 2007 to 46.3 million in 2008, and an estimated 
120 million people did not have any dental insurance (Census, 2009). 
   
This demand-supply gap has resulted in a lucrative business development opportunity for 
several countries like India, Thailand, Singapore, Turkey, Dubai and others where labor, both 
skilled and unskilled, and infrastructural facilities costs are considerably lower.   Prices therefore 
differ widely between U.S. and some of these destinations; for example in 2009 a heart valve that 
cost $100,000 in the U.S. cost only $10,000 in India (Anand, 2009); eye surgery that cost $3700 
was only $730 in Thailand ; a knee replacement surgery that cost $50,000 in the U.S. cost $6000, 
and  heart surgery that cost $60,000-80,000 in the U.S. cost 10,000 in the Philippines (Awadzi & 
Panda, 2007).  
 
Medical tourism thus has resulted in a 60 billion dollar global industry impacting 
consumers, suppliers, destinations, governments, and third party facilitators (Singh, 2008). As a 
field of study it is multidisciplinary; drawing from fields of tourism, hospitality, medicine, law, 
ethics, sociology, and psychology, among others.  In recent years it has received extensive media 
attention and has been the subject of numerous conferences. 
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The Deloitte report on medical tourism projects that outbound medical tourism from the 
US alone could reach upwards of 1.6 million patients by 2012, with sustainable annual growth of 
35 percent (Deloitte, 2009). Given the importance and potential of medical tourism, surprisingly 
it has not received much scholarly interest as there has not been a systematic stream of research 
in the tourism and hospitality domain.  While scholars from fields of medicine and law have 
examined specific issues like health impacts, fiduciary requirements, applicability of existing 
laws for medical tourism (Balaban & Marano, 2010; Brady, 2007; Burkett, 2007; de Arellano, 
2007) and there is research regarding medical tourism in individual countries, like India, 
Thailand, Malaysia (Aizura, 2009; Chee, 2007) , a stakeholder approach to medical tourism is 
currently lacking.   
 
The purpose of this paper therefore is to focus on the most salient stakeholder, the 
consumer, and examine the components of the consumer’s decision to seek medical tourism.  
This paper also identifies several other stakeholders in the industry and their role in influencing 
the consumer’s decision, and in facilitating or inhibiting the actual travel.   Our main 
contribution lies in analyzing the stages of consumer decision-making for medical tourism and 
developing testable propositions for future empirical work.  Our study has implications for policy 
makers both in the host and destination countries and also for marketing professionals in 
stakeholder institutions. 
 
 The rest of the paper is organized as follows:  Section 2 describes the common types of 
medical tourism, identifies some of the motivations and demand triggers for the travel, and the 
prevailing facilitating factors.   Section 3 explains the components of decision-making and the 
role of the various stakeholders involved.  Section 4 provides the conclusions, limitations, and 
suggestions for future research.   
 
 
TYPES AND NEED FOR MEDICAL TOURISM 
 
 
Medical tourism is generally delineated into three broad types: cosmetic, dental and general.  
Cosmetic surgery was the most popular form of medical travel until the advent of modern 
medical tourism.  Travel to seek dental care (root canals, cosmetics, implants etc.) and general 
care (knee and hip replacement, eye surgery) form the other types of medical travel. While health 
and wellness tourism like travelling to health resorts, spas, hot springs etc., is common and 
people often settle down in reasonable priced retirement homes with luxurious amenities like 
massage etc. such travel is not commonly considered medical tourism especially when the 
purpose is long-term stay.  
 
 
 
 
 
 
 
 
Graph 2 
Medical Tourism Branches 
 
 
The motivation for medical tourism can be attributed to several reasons:  
Cost: Consumers from developed markets, particularly from United States with discretionary 
medical needs seek lower cost (Ehrbeck, Guevara, & Mango, 2008). The price differential for 
various medical procedures and the desire to reap cost advantages is the primary motivation for 
medical tourism (Marlowe & Sullivan, 2007).  Table 1 provides a comparison of costs of various 
procedures in different countries.  While the primary reason for the difference in costs is lower 
salaries for doctors, nurses, and staff, other factors like low cost or no medical malpractice 
insurance or low infrastructural and overhead costs also play a role in lowering costs and prices, 
which are sometimes a fraction of those in developed countries.  The cost factor is especially 
important to the millions of uninsured (the U.S. Census Bureau puts this figure at 46 million in 
2009) who can ill-afford even simple surgical procedures in developed countries that do not 
provide universal health coverage, for e.g. U.S.  
 
 
Table 1 
The Cost of Medical Procedures in Selected Countries (In U.S. Dollars) 
 
Procedure 
U.S. 
Retail 
Price 
U.S. 
Insurers* 
Cost 
India** Thailand** Singapore** 
Angioplasty $98,618 $44,268 $11,000 $13,000 $13,000 
Heart bypass $210,842 $94,277 $10,000 $12,000 $20,000 
Heart-valve 
replacement (single) $274,395 $122,969 $9,500 $10,500 $13,000 
Hip replacement $75,399 $31,485 $9,000 $12,000 $12,000 
Knee replacement $69,991 $30,358 $8,500 $10,000 $13,000 
Gastric bypass $82,646 $47,735 $11,000 $15,000 $15,000 
Spinal fusion $108,127 $43,576 $5,500 $7,000 $9,000 
Mastectomy $40,832 $16,833 $7,500 $9,000 $12,400 
*Retail prices and insurers' cost represent the mid-point between low and high ranges 
** U.S. rates include at least one day of hospitalization; international rates include airfare, 
hospital and hotel 
Medical 
Tourism
Cosmetic 
Surgery
Non-Cosmetic 
Surgery Dental
P1: The greater the difference in cost between the medical procedure in home country versus 
destination country, greater the probability of the consumer undertaking medical tourism, ceteris 
paribus. 
 
Waiting Lists and Availability:  Even though several developed countries have nationalized 
health care systems such as Britain and Canada, waiting time for certain procedures can be 
greater than 18 months (see Tables 2 and 3) and treatment in private clinics can be expensive or 
unavailable.  Furthermore, patients seeking alternative medicinal treatments may have to travel 
overseas as their home countries may not have the technology, equipment and facilities, while 
still others require the approval of a government agency. For e.g. if FDA approval for certain 
procedures is not forthcoming, but alternative treatments are available in other countries, patients 
may choose to travel instead of waiting for FDA’s lengthy approval process. Society and 
regulatory agencies may impose restrictions on certain treatments like stem cell therapy, 
surrogate pregnancies, organ transplants, sex determination of unborn child etc., (Horowitz and 
Rosensweig, 2007) leading to the need for travel to seek such treatment.  
 
 
Table 2 
Waiting times for treatment in Canadian Hospitals 
Median numbers of weeks 
 
 
Quebec  New Brunswick 
Nova 
Scotia 
Prince 
Edward   
Newfoundland 
& Labrador  
Plastic Surgery  26.1 33.9 46.3 13.6 16 
Gynecology  6.4 8.3 8.1 17.8 11.1 
Ophthalmology  11.8 11.7 8.4 17.4 11.7 
Otolaryngology  6.1 9.3 13.6 26.6 5.8 
General Surgery  7.2 5 6.6 2.8 3.8 
Neurosurgery  12.7 32.3 11 3.2 
Orthopedic Surgery 20.3 18.1 87.4 23.2 18.8 
Cardiovascular Surgery 
(Urgent)  0.6 4.2 1.4 2.4 
Cardiovascular Surgery 
(Elective)  4.7 11.5 5.7   2.9 
Urology  4.4 10.1 13.7 4.3 17.7 
Internal Medicine  9.4 7.5 7.1   17.5 
Radiation Oncology 4.7 4.6   1.8   
Medical Oncology  1 1.6 2.6 2 2.2 
 
Source: (Fraser-Institute, 2008 ) 
 
 
 
 
 
 
 Table 3 
Average waiting time for admitted patients in United Kingdom 
 
Admitted Patients Average waiting time in 
weeks in UK 
Cardiology  5.2 
Cardiothoracic Surgery  6.6 
Dermatology  6.8 
Ear, Nose & Throat  8.4 
Gastroenterology  3.6 
General Medicine  3.1 
General Surgery  7.4 
Geriatric Medicine  1 
Gynaecology  6.1 
Neurology  3.3 
Neurosurgery  9.5 
Ophthalmology  9.3 
Oral Surgery  10.5 
Plastic Surgery  7.5 
Rheumatology 3.2 
Thoracic Medicine  2.6 
Trauma &  Orthopaedics  10.9 
Urology  6.2 
Other  5.4 
Source:  (Department-of-Health, 2009) 
 
 
P2a.  The greater the waiting time in the home country for the desired medical procedure, the 
greater the probability of the consumer undertaking medical tourism abroad, ceteris paribus 
 
P2b.  The lower the availability of, and access to, the desired treatment in the home country, the 
greater the probability of the consumer undertaking medical tourism abroad, ceteris paribus.  
  
Privacy and Confidentiality: There are privacy concerns of the patients when own country used 
to perform the procedure (Vitalis & Milton, 2009). Although the U.S. has laws that safeguard the 
privacy of medical records under HIPAA, insurance companies, courts etc. can have access to 
these records.  Procedures undertaken in other countries that have no reporting requirements can 
ensure privacy and confidentiality of services like drug rehabilitation, cosmetic/plastic surgery, 
sex change etc.  
  
P3: The greater the desire for privacy and confidentiality of the desired treatment, the greater 
the probability of the consumer undertaking medical tourism abroad, ceteris paribus.  
 
While the above mentioned demand triggers impact a consumer’s need for medical travel 
there are several facilitating or enabling factors that need to be considered when evaluating the 
decision process. 
 
Lower travel costs, and the lure of a vacation:  The ease and affordability of the international 
travel has increased in recent years with discount packages available through third party vendors 
like online travel agents.  Moreover, the idea of combining recuperation in an exotic vacation 
spot along with a medical procedure seems appealing to many people (Conell, 2006). Similarly, 
with the increasing demographic diversity and globalization of the workforce in developed 
nations combining a visit “home” with medical treatment augments demand for medical tourism. 
 
Access to information via the internet to hospital sites, travel agents specializing in arranging 
medical tours, blogs of past patients, reduces the information asymmetry normally associated 
with seeking treatment in hitherto unknown places.  Moreover several host countries and airlines 
provide incentives for travel like expedited visa processing, discounted airfares and free extra 
baggage allowances. 
 
Travel intermediaries:  An ordinary search on Google for medical tourism generated more than 
10 million hits, several of which relate to third party intermediaries who plan and execute the 
entire itinerary- (from selecting the hospital for the procedure, the destination for holiday as well 
as to making arrangements for post-procedure care upon return to the home country).  These tour 
operators act as brokers between the consumers and providers of medical tourism and thus 
reduce transactions costs, inducing travel. 
 
Employer and Insurance Company endorsements:  Due to the financial savings realized through 
medical tourism, several employers and insurance companies have endorsed institutions in other 
countries for treatment overseas.  For e.g. Blue Cross Blue Shield in South Carolina and 
Wellpoint in Wisconsin have tie-ups with Bummugrad International Hospital in Thailand and 
Apollo Hospitals in India where expenses can be reimbursed in full, including the airfare for the 
patient and a companion (Deloitte, 2009).   
 
 While the personal need to undertake medical tourism and the facilitating factors 
establish the impetus to seek medical travel, the decision to actually undertake the travel has 
several other components that we describe below. 
 
 
COMPONENTS OF DECISION MAKING AND STAKEHOLDER ROLE 
 
 
Contrary to purchase decisions for simple products or services (like eating in a fast food 
restaurant), the decision to undertake travel abroad, and especially travel to seek medical 
treatment is highly involved, complex, multi-faceted, and often emotional in nature (Crouch & 
Louviere, 2001).  The decision affects both the physical (the success of the medical procedure) 
and mental well-being (the vacation/ tourism portion) of the consumer for an extended time.  
Moreover, the decision involves not only the quality of the actual service itself, but also the 
perceptions of several stakeholders and related service providers, in addition to input and support 
from family members.  Figure 1 depicts a model of the consumer’s decision components 
involved for medical tourism. 
 
 
 
 
The Pre-decision phase of the model establishing consumer need for the travel and the 
facilitating factors has been discussed in Section 1.  We now proceed to discuss the information 
search and evaluation of alternatives that eventually lead to the decision to travel.
 
Role of Stakeholders: 
While stakeholders are understood as persons, groups, systems or entities that affect or are 
affected by an organization’s actions, in this context we use the term stakehol
entities that are integrally involved in the medical tourism industry and are interconnected such 
that they form a choice set for the consumer (Crouch and Louviere, 2001).  While there are 
relational, psychological and demographic variable
to engage in medical tourism (role and support of family and friends, personality characteristics 
like openness to experience; or level of income and education) we restrict this discussion to 
identifiable influences on the potential consumer.
 
Destination Country Profile: 
technological profile of the destination country would play a role in the decision
 
Figure 1 
Decision Components 
s that may affect the propensity of a consumer 
 
While the economic, political, legal, socio
 
 
ders to describe 
-cultural, and 
-making process 
for any tourist activity, these dimensions assume even greater importance in the context of 
medical tourism (see (Forgione & Smith, 2007).   
 
P4: The lower the institutional and cultural distance between the destination country and home 
country of the consumer, the greater the probability of the consumer seeking undertaking 
medical tourism in that country, ceteris paribus.  
 
Hospital / Treatment facility accreditation and reputation:  Selecting the appropriate doctors and 
hospital is generally considered an important decision for selecting a medical facility, although 
Carabello (2008) posits that most of the American travelers chose a facility based on destination 
interest combined with medical services. Rating agencies like JCI, Patients Beyond Borders, 
Trent Accreditation Scheme, International Organization for Standardization etc. play a vital role 
in increasing consumer trust in the facilities providing treatment (Heung, Kucukusta, & Song, 
2010).  The general reputation of the institution providing the medical services in terms of 
cleanliness, safety, service quality, amenities, nursing staff competencies will also affect the 
consumer trust and the likely selection of the facility. 
 
P5: The higher the rating of the treatment facility and the perception of service quality of the 
treatment, the greater the probability of the consumer undertaking medical tourism at that 
facility, ceteris paribus 
 
Personal Factors:  Seeking medical treatment in unfamiliar surroundings can increase anxiety 
and generate greater feelings of vulnerability than when surroundings are known and familiar.  
Hence personal dispositions like openness to experience and prior experience to the culture and 
language can be enabling factors in the decision to undertake medical travel abroad.  Similarly 
we believe that demographic variables like age, income and education can also impact the 
decision to travel to another country for medical and tourism services. 
 
DISCUSSION, LIMITATIONS, AND FUTURE DIRECTIONS 
 
 
The propositions derived above describe only some of the main factors influencing the 
consumer’s decision components with respect to medical tourism.  The evaluation of alternatives 
will eventually lead to the travel /purchase and post experience evaluation.  The next logical step 
is to empirically test the model both through qualitative and quantitative research.  While large 
scale quantitative data may be difficult to come by due to the sensitive nature of the data and 
reluctance both by consumers and providers to disclose medical information, it is possible to 
interview and survey consumers and obtain secondary data from blogs and provider sites.   
Future research can also identify the several limitations of medical tourism, the ethical and legal 
issues, the detrimental or positive impact on host and destination medical providers, and the 
economic impact on destination countries.  As such, medical tourism provides a rich context for 
conducting tourism research. 
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